Microscope Market Will Rise as Growing Demand for Advanced and High Resolution Microscopes

June 12, 2019: The global microscope market size is expected to reach USD 15.1 billion by 2026 registering a CAGR of 7.9%. Growing demand for advanced and high resolution microscopes for conducting R&D in the fields, such as life sciences and nanotechnology, is expected to drive the market over the forecast period. Emergence of new application areas, such as quantum dots and miniature transistor chips, will further boost the market growth. Quantum dots technology is currently in a nascent stage and is expected to cater to multiple application areas including in transistors, diode lasers, quantum computing, biological imaging, solid-state lighting, electroluminescent displays, and photo-voltaic cells. Optical devices led the market in 2018, owing to their large application base. However, due to high adoption of advanced microscopes, scanning probe and electron microscopes are expected to gain share over the coming years.

Request a Free Sample Copy of Microscope Market Report @  https://www.radiantinsights.com/research/microscopes-market/request-sample

Scanning probe devices is expected to be the fastest-growing product segment from 2019 to 2026. Features, such as non-dependence on wavelength of the source light, resolving atoms, and generating better 3D maps of surfaces, are some of the factors expected to drive the demand of these products. North America led the global market, in terms of revenue, in 2018 and is likely to reach USD 4.7 billion by 2026.

Further key findings from the study suggest:

• Semiconductors and life sciences were the dominant application segments in the global microscope market

• However, nanotechnology is expected to be the fastest-growing application with a CAGR of 9.3% from 2019 to 2026

• Asia Pacific is expected to be the fastest-growing regional market with a CAGR of 9.1% from 2019 to 2026

• High demand for semiconductors and positive outlook on application markets are expected to be the key drivers responsible for the market growth in the region

• Key companies in the market include Olympus Corporation, Hitachi High-Technologies Corporation, Nikon Corporation, FEI Company, JEOL Ltd., Carl Zeiss, and Leica Microsystems

For further inquiries, about - Global Industry Analysis, Size, Growth, Trends and Forecast 2019 - 2026, click on this link – https://www.radiantinsights.com/research/microscopes-market

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Applications
1.1.3 Regional scope
1.1.4 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR's internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for Primary interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:

To read more reports of this category, Visit our blog:  https://healthcarepharmamedicaldevices.home.blog

About Radiant Insights, Inc

Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Medical Oxygen Concentrators Market Will Boost Due To Rising Prevalence Of Respiratory Diseases

June 11, 2019: The global medical oxygen concentrators market size is projected to reach at USD 2.88 billion expanding at a CAGR of 7.4. Key factors boosting the market include rising prevalence of Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases and increasing geriatric population, which is highly susceptible to chronic diseases. In addition, constant technological advancements in the field is likely to drive the market further.

Request a Free Sample Copy of Medical Oxygen Concentrators Market Report @  https://www.radiantinsights.com/research/medical-oxygen-concentrators-market/request-sample

According to data published by the United Nations, global geriatric population is expected to increase from 962 million in 2017 to 2.1 billion by 2050. Based on product type, the market is classified into portable and stationary oxygen concentrators. The portable product segment is expected to register the highest CAGR over the forecast period on account of increasing target population base, rising cases of COPD, and demand for lightweight and portable concentrators. Advantages offered by these produces, such as smaller size and improved portability, are also likely to augment their demand over stationary devices.

On the basis of application, the market is classified into homecare and non-homecare. Homecare was the dominant segment in 2018 and is anticipated to expand at the fastest CAGR from 2019 to 2025. This is attributed to the factors, such as growing geriatric population and increasing demand for healthcare oxygen therapies. Homecare oxygen concentrators provide independence of use, which allow patients to complete their day-to-day activities with ease, this is also said to boost their demand. Asia Pacific is anticipated to be the fastest-growing regional market at a CAGR of 8.3% from 2019 to 2025.

Download Full Research Report on “Medical Oxygen Concentrators Market” @  https://www.radiantinsights.com/research/medical-oxygen-concentrators-market

Further key findings from the study suggest:
• Portable devices led the global medical oxygen concentrators market in 2018 owing to their advantages over the stationary devices
• Homecare was the dominant application segment in 2018 owing to increased geriatric population, prevalence of COPD, and need for homecare oxygen therapies
• North America led the global market with a revenue of USD 687.9 million in 2018 and is anticipated to maintain its dominance over the forecast period
• This is growth is attributed to the developed homecare and healthcare services and favorable reimbursement policies in the region

• Key companies in the market are Invacare Corp.; Drive DeVilbiss Healthcare, Inc.; Philips Healthcare; Nidek Medical; Covidien Ltd.; AirSep Corporation; Inogen, Inc.; and ResMed

Dental Equipment Market Will Rise Due To Increased Awareness Regarding Dental Hygiene

June 10, 2019: The global dental equipment market size is expected to reach USD 10.47 billion by 2025, it is anticipated to expand at a lucrative CAGR of 4.5% over the forecast period. Key factors attributed to the growth include increasing demand for dental procedures owing to prevalence of dental disorders and rising awareness and demand for preventive, restorative, and surgical services for dental care. Moreover, favorable government initiatives regarding dental hygiene is also a significant factor responsible for driving the market. Due to increasing number of initiatives, there is an increase in awareness regarding dental hygiene leading to increasing adoption of dental treatments, which in turn is anticipated to drive the market for dental equipment over the forecast period.

Dental equipments are classified on the basis of product into dental radiology, dental lasers, systems and parts, laboratory machines, hygiene equipment, and others. The systems and parts segment held the leading market share of 39.9% in 2018 and is anticipated to grow at a lucrative pace over the forecast period. The segment is further classified into instrument delivery systems, vacuums and compressors cone beam CT systems, cast machines, furnace and ovens, CAD/CAM, and electrosurgical equipment. The CAD/CAM sub-segment led in 2018 owing to the technological superiority of these equipment over traditional die casting techniques.

Request a Free Sample Copy of Dental Equipment Market Report @   https://www.radiantinsights.com/research/dental-equipment-market/request-sample

North America led with a market share of 29.6% in 2018. Some of the key reasons attributed to the high share include technological advancements, rising demand for dental surgeries, growing geriatric population, and increasing number of dentists and dental clinics. On the other hand, Asia Pacific is expected to expand at the fastest CAGR of 4.9% over the forecast period. Constantly developing healthcare infrastructure and increasing healthcare expenditure coupled with the presence of high unmet medical needs are expected to serve this market as high-impact rendering drivers.

Few significant companies venturing in the market include, Denstply International Inc.; A-Dec Inc.; Planmeca Oy; Sirona Dental Systems Inc.; Patterson Companies Inc.; Straumann; GC Corporation; Carestream Health Inc.; Biolase Inc.; Danaher Corporation; and 3M.

Further key findings from the report suggest:
• Systems and parts product segment led the market in 2018 and is anticipated to grow at a lucrative rate over the forecast period
• CAD/CAM sub-segment of systems and parts accounted for the largest market share in terms of revenue in 2018, owing to technological advancements
• North America led the dental equipment market in 2018 with a revenue share of USD 1.84 billion owing to the presence of advanced healthcare facilities and strong reimbursement scenarios
• Some of the key players operating in the market are, Cook Medical; Smiths Medical; Edwards Life Sciences Corporation; Medtronic Inc.; and Johnson & Johnson.

The report “Dental Equipment Market to 2025” is available now at  https://www.radiantinsights.com/research/dental-equipment-market

About Radiant Insights, Inc
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Home Infusion Therapy Market Size Is Expected To Reach USD 38.7 Billion By 2026

June 07, 2019: The global home infusion therapy market size is expected to reach USD 38.7 billion by 2026 registering a CAGR of 7.2% from 2019 to 2026, according to a new report by Radiant Insights, Inc. Rapid technological advancements are some major factors contributing to the market growth. Home infusion is gradually being considered as an alternative to extended stay in hospitals or nursing homes for patients suffering from chronic diseases. With the administration of medications in home settings, patients recover faster, are more comfortable, and save money. Several government and non-government programs aimed at reducing the burden of hospital stays by establishing infusion centers that provide quick IV infusion services are likely to have a positive impact on the market.

Request a Free Sample Copy of Home Infusion Therapy Market Report @  https://www.radiantinsights.com/research/home-infusion-therapy-market/request-sample

Furthermore, favorable government policies and regulations are expected to propel the industry growth. In addition, rising prevalence of diseases, such as Cardiovascular Diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to be a high impact rendering driver for the market. According to the WHO, at present, all the aforementioned diseases account for 60% of total deaths and 43% of the disease burden in U.S. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids, which in turn, is expected to boost the market growth in the region.

Further key findings from the study suggest:

• Infusion pumps led the product segment in 2018 owing to their extensive use for the delivery of fluids, such as medications and nutrients, during infusion therapy

• Needleless connectors is the fastest-growing product segment over the forecast period. These devices provide protection from needlestick injuries

• Anti-infective segment held the largest share in 2018 owing to a large number of procedures performed for administering antibiotics and antifungals

The report “Home Infusion Therapy Market Size, Share & Trends Analysis Report” is available now at https://www.radiantinsights.com/research/home-infusion-therapy-market 

• The chemotherapy segment is expected to witness lucrative growth during the forecast period on account of initiatives undertaken pertaining to cancer treatment, such as development of infusion centers by the Cancer Treatment Centers of America

• The market is highly competitive and is marked by the presence of key companies, such as B. Braun Melsungen AG; ICU Medical, Inc.; Baxter; Fresenius Kabi AG; Caesarea Medical Electronics; Terumo Corporation; CareFusion Corporation; JMS Co. Ltd.; and Smiths Medical

• Most of these companies focus on new product development to maintain their position in the global home infusion therapy market

Immuno-Oncology Market Will Grow Due to Rise in Cancer Patients and Favorable Reimbursements

May 06, 2019: The global immune-oncology market is anticipated to rise at a significant CAGR in the forecast period. Immune-oncology market is driven by factors such as manufacturers’ emphasis on upgrading immune-oncology drugs as well as increase in R&D to develop anti-cancer drugs. Development of innovative products coupled with product launches is anticipated to propel market growth soon. Increasing advances in healthcare settings and use of innovation in medical sector are now emphasizing better services to offer to cancer patients, which in turn has bolstered the immune-oncology market.


By Type, the immune-oncology market segmentation includes mAb (Naked, Conjugate), Cancer Vaccines and Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4). By Application, the immune-oncology market is segmented as Lung, Melanoma, Leukemia, and Lymphoma. Leukemia and lymphoma account for a higher market due to rise in prevalence and low medical attention. Lung diseases witnessed a remarkable CAGR due to rise pollution and change in lifestyle.


Request a Free Sample Copy of Immuno-Oncology Market Report @  https://www.radiantinsights.com/research/immuno-oncology-market/request-sample


Geographical segmentation for immune-oncology market includes North America, Latin America, Europe, Middle East, Asia-Pacific and Middle East and Africa. North America dominates the market growth in the global scenario owing to rise in improvements in healthcare settings and improved medical care. Advances in medicines and mode of drug administration also propels the growth of U.S. market. European market is expected to follow the same trend with a slight difference of reimbursement scenario. Favorable reimbursement for medical and cancer cases fuels the market.

Asia-Pacific regions account for a significant market share in the global scenario rise in cancer patients and favorable reimbursements. Prominent players in the immune-oncology market include Amgen, Inc. AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Pfizer Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, AbbVie, Inc., Eli Lilly and Company, Merck & Co., Prometheus Therapeutics & Diagnostics, Sanofi S.A., EMD Serono, Inc., Aduro BioTech, Galena Biopharma, Bavarian Nordic, Celldex Therapeutics, ImmunoCellular Therapeutics, Gilead Sciences Inc. and Incyte.


Immuno-oncology is a unique approach that uses the body’s immune system to fight cancer. These therapies activate an individual’s immune system, making it able to recognize cancer cells and destroy them. Immuno-oncology therapies provide long lasting anti-cancer benefits to patients who previously had very few treatment options available to them. These therapies work against a large number of cancer types. The technological advancements are helping the growth of immuno-oncology market. The biotechnology and pharmaceutical companies are striving to launch new and most effective therapies.


The report “Immuno-Oncology Market Report” is available now at  https://www.radiantinsights.com/research/immuno-oncology-market


According to the report “Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022”, the global immuno-oncology market is anticipated to cross US$ 100 Billion by 2022. The report provides a detailed analysis of the global immuno-oncology market. The report also provides the current and forecasted market for immuno-oncology.


Furthermore, the report provides insights about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. In addition, the report also highlights various opportunities available for growth of the global immuno-oncology market. Moreover, the report provides the sales of major marketed immuno-oncology drugs.


The global immuno-oncology market has been segmented on the basis of type of product into monoclonal antibodies, therapeutic vaccines, and immune checkpoint inhibitors amongst others. According to the report, monoclonal antibodies segment was estimated to account for the largest share in 2016 due to rising prevalence of cancer & rising usage in a number of therapies (antibody-directed enzyme pro-drug therapy and radio immunotherapy).


The report also sheds light on the geographic segmentation of the global immuno-oncology market. In 2016, North America was estimated to account for the largest share. Presence of major players, increased awareness and better distribution mechanisms are some of the prominent factors that have led to North America being the market leader.


Based on type of cancer, the immuno-oncology market is dominated by Lung Cancer & Melanoma applications with several companies and academic institutions focusing on novel treatment approaches, thus making the major contribution to the global immuno-oncology market. The report provides the market analysis of major indications along with the forecast till 2022.


A major focus has been on the ongoing clinical trials for the development of innovative products. In this context, the report provides information about the immuno-oncology programs at various stages of clinical development. In addition, the report highlights the strategic collaborations amongst the players for enhancing their market share.





The later part of the report discusses some of the prominent players in the global immuno-oncology market. Market share analysis of major players is also provided in the report. Furthermore, a brief business overview of each player has been provided along with their product and pipeline portfolios and recent developments. Overall, immuno-oncology is an important and rapidly emerging field. This report will prove as a complete source of knowledge and analysis for clients and potential investors.

Genetic Testing Market Is Estimated to Grow Due to The Growing Awareness and Increasing Investments

April 25, 2019: Global Genetic Testing Market is estimated to grow significantly in the forecast period due to the growing awareness and increasing investments in the domain. Genetic testing (DNA testing) is a form of medical test that determines any modification in the genes, chromosomes and proteins. The result of the test identifies any suspected genetic disorder or help decide an individual’s chance of curing the genetic condition.

Genetic testing also helps in detection of karyotype for medical purposes. The awareness of genetic testing is increasing because of numerous benefits offered by the procedure like determination of genetic deformities in early gestation period. Moreover, the test also helps to identify sex of the fetus while pregnancy. Owing to the increasing awareness and discoveries in the domain, genetic testing market is expected to grow significantly in the coming years. From among all the tests conducted for genetic testing, (CFTR) Cystic Fibrosis Trans-Membrane Conductance Regulator with screening for gene mutations is widely conducted.

Request a Free Sample Copy of Genetic Testing Market Report @  https://www.radiantinsights.com/research/global-genetic-testing-market-outlook-2022/request-sample

In personalized medicines, where customization is done for patients with an understanding of molecular base of disorder has become prevalent over the years. To understand the molecular base of any disorder, genome sequencing and genetic testing are the essential tools. People are screened for numerous genetic disorders since early detection can prevent the growth of symptoms or minimize the severity of the disorder. For diagnosis of cancer, genetic testing can identify the predisposition of the disorder in the gene before its indication (symptoms), which helps the individual to take precautionary measures and avoid the further possible risks.

Currently, insurance is considered as an important asset for any individual. Unfavorable reimbursement by insurance firms prevents people from conducting genetic tests, which in turn might restrain the growth of genetic testing market. Also, the significant costs for genetic tests affects genetic testing market unfavorably. Furthermore, high-import duty by government for genetic test kits is yet another obstacle to the growth of genetic testing market.

Modernization in techniques of genetic testing, increased accuracy and efficiency are predicted to bring new opportunities in the market. Additionally, flourishing market holds a promising growth of genetic testing market owing to increase in number of patients and rising awareness in the developed nations. Increasing popularity of modern techniques and focus from clinical science to bioinformatics are few major trends witnessed in genetic testing market, which leads to the high rate of adoption. Besides, a new genetic test has been developed that can envisage dementia risk in an individual prior 10 years. With the help of this technique, the patients can target for intervention and reduced risk.

The report “Global Genetic Testing Market Outlook 2022” is available now at  https://www.radiantinsights.com/research/global-genetic-testing-market-outlook-2022

Genetic testing market is categorized based on test type, service provider, application and geography. On the basis of test type, genetic testing market is divided into prenatal testing, newborn screening, predictive & presymptomatic testing, pharmacogenomic testing, and forensic testing. In terms of revenue, predictive & presymptomatic testing held larger share market in the past years. The segment is expected to propel genetic testing market in the forecast period owing to the early detection of disorders and increasing awareness about conditions like cancer.

Based on service provider, genetic testing market is split into diagnostics laboratories, hospital-based laboratories, specialty clinics, and others. Owing to patient convenience and growing number of hospitals, hospital-based laboratories segment is expected to register significant growth in the coming years.

In terms of application, genetic testing market is divided into oncology, infectious diseases, autoimmune diseases, and others. Oncology segment is expected to lead the genetic testing market in future due to the rising prevalence of cancer across the globe. Geographically, genetic testing market is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Among these, few regions of North America like Germany, U.S and England are predicted to dominate genetic testing market owing to the developed infrastructure and rising investments in these nations.

To read more reports of this category, Visit our blog:  https://healthandpharamceuticalri.blogspot.com

The major players of genetic testing market comprise 23andMe, Abbott Molecular, Biocartis, BioHelix, BioMerieux, Bayer Diagnostics, BGI, Celera Genomics, deCODEme, Genentech, HTG Molecular Diagnostics, Pathway Genomics, Genomictree, Genomic Health, IntegraGen, LabCorp Diagnostics, Luminex, MolecularMD, Myriad, Natera, PacBio, Qiagen, Roche Diagnostics, and Siemens, Cepheid, Counsyl, and Sequenom. The advent of genetic tests has revolutionized the molecular diagnostics and cytogenetic industry. It is one of the most rapidly growing segments in molecular diagnostics industry, which helps in delivering customized health services or personalized medicine. The share of genetic testing is incessantly increasing in the market. Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.

The report “Global Genetic Testing Market Outlook 2022” provides a detailed analysis of the genetic testing market. The report also provides an insight regarding the current and future prospective of the market. This report covers the major trends and drivers, and their impact on the market. The report also discusses some of the restraints that can hinder the growth of the market, as well as rising opportunities which can provide new dimensions to the industry.

Cardiovascular and Soft Tissue Repair Patches Market Will Rise Due to Growing Prevalence of Hernia

April 22, 2019: The global cardiovascular and soft tissue repair patches market size is expected to reach USD 5.71 billion by 2025, at a CAGR 8.2 % over a forecast period, according to a new report by Radiant Insights, Inc. Increasing application of these patches in medical procedures and sports injuries and rising prevalence of heart defects such as atrial septal defect and ventricular septal defect are some of the factors driving the demand.

Growing prevalence of Cardiovascular Diseases (CVDs) is one of the key market drivers. According to the American Heart Association, cardiovascular diseases accounted for nearly 800,000 deaths in the U.S. in 2017. Moreover, the prevalence of heart attacks is significantly high in the country. Nearly, 790,000 U.S. adults suffer from heart attack each year. Coronary heart diseases account for the majority of CVD deaths followed by heart attack and stroke. High prevalence of such diseases is anticipated to create lucrative growth opportunities for the market.

Growing prevalence of hernia is also one of the key market drivers. Key risk factors for hernia are abdominal surgery, heavy weight lifting, chronic cough, constipation, ascites (fluid in abdomen), and other conditions that increase pressure on the intra-abdominal region. Furthermore, nerve damage, loss of tissue strength, and genetic factors lead to weakening of muscles. Congenital hernia is due to residual embryological channel defect and family history. According to a survey, in 2016, around 20 million repairs of inguinal hernia were carried out each year across the globe. Thus, the demand for these patches in healing the wounds post operation is anticipated to grow significantly over the years.

The report “Cardiovascular and Soft Tissue Repair Patches Market” is available now at https://www.radiantinsights.com/research/cardiovascular-and-soft-tissue-repair-patches-market

Further key findings from the report suggest:

• In 2018, soft tissue repair held the largest market share in terms of revenue owing to the increasing prevalence of hernia

• Cardiac repair segment is expected to witness rapid growth over the forecast period owing to high prevalence of congenital heart diseases coupled with improving treatments globally

• ePTFE segment accounted for the largest revenue share of raw materials in 2018 however biomaterial and tissue engineered materials segment is expected to register the fastest CAGR over the forecast period

• In 2018, North America held the largest revenue share due to high prevalence of diseases and easy access of treatment alternatives

• Asia Pacific is expected to emerge at the fastest CAGR over the forecast period owing to growing prevalence of congenital heart diseases and hernia

• Key players operating in the cardiovascular and soft tissue repair patches market include Edwards Life Sciences; Cryolife; Baxter; Bard Peripheral Vascular Inc.; and W.L.Gore & Associates.

Request a Free Sample Copy of Cardiovascular and Soft Tissue Repair Patches Market Report @ https://www.radiantinsights.com/research/cardiovascular-and-soft-tissue-repair-patches-market/request-sample

About Radiant Insights, Inc


Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Enteral Feeding Formulas Market Growth Will Be Positively Impacted Due To Rise In Number Of New Product Launches

April 17, 2019: The global enteral feeding formulas market size is expected to reach USD 8.71 billion by 2025, at a CAGR 7.2% over a forecast period, according to a new report by Radiant , Inc. It is majorly driven by growing prevalence of chronic diseases including cancer, diabetes, inflammatory bowel disease, liver disease, and neurological conditions. Manufacturers are increasingly focusing on developing formulas that cater to specific therapeutic needs of these patients. Rise in number of preterm births is also one of the significant factors that propel the product demand to meet nutritional requirements of the newborns.

Increasing number of home care and nursing care centers also indicates the surge in demand for these formulas, as a large number of chronically ill as well as geriatric patients are the key consumers for these products. Growing demand for these products for treating conditions associated with pregnancy also contributes to market growth. In addition, recent product developments and rise in number of new product launches may positively impact the growth.

Request a Free Sample Copy of Enteral Feeding Formulas Market Report @  https://www.radiantinsights.com/research/enteral-feeding-formulas-market/request-sample 

Rise in prevalence of hospital associated malnutrition among both adults and children drives the demand for enteral feeding formulas. Increasing implementation of the number of government programs for creating awareness regarding enteral tube feeding may also support increasing adoption. Moreover, favorable reimbursement policies in developed countries cover tube feeding procedures that may impel the enteral feeding formulas market over the forecast period.

Further key findings from the report suggest:
• Disease-specific formula segment is expected to emerge at the fastest CAGR of 8.6% over the forecast period owing to high prevalence of chronic diseases coupled with recent product developments
• Adults segment held the largest market share in terms of revenue in 2018 due to high availability and increased adoption of tube feeding formulas among adults
• In 2018, oncology led the application segment with the largest revenue share owing high prevalence of cancer induced malnutrition
• Home care end use segment is expected to grow lucratively over the forecast period
• North America held the largest revenue share in 2018 owing to favorable reimbursement policies and rising burden of cardiovascular diseases
• Asia Pacific is expected to witness the fastest CAGR 8.7% over the forecast period
• The enteral feeding formulas market is fairly competitive with the presence of companies such as Abbott; Nestle Health Science, Danone Nutricia; Fresenius Kabi AG; and MEIJI HOLDING AND CO.

Download Full Research Report on “Enteral Feeding Formulas Market” @  https://www.radiantinsights.com/research/enteral-feeding-formulas-market 

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR's internal database
1.3.3 Secondary sources & third-party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Enteral Feeding Formulas Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospects Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.4 List of Key End-users

Preimplantation Genetic Testing (PGT) (PGS/PGD) Market will grow at a CAGR of 6.2% Over the Forecast Period

April 16, 2019: The global preimplantation genetic testing market is expected to reach USD 107.3 million by 2024, at a CAGR of 6.2% over the forecast period, according to a new report by Radiant Insights, Inc. It is primarily driven by a rising awareness among couples to undergo diagnostic and screening tests to minimize genetic diseases and aneuploidy in fetus. The ability of preimplantation genetic testing to detect genetic disorders and rare diseases, such as fibro dysplasia ossificans progressive, is anticipated to propel the growth.

High adoption of In Vitro Fertilization (IVF) technique consequently upsurges the utilization of Preimplantation Genetic Diagnosis (PGD). These techniques are advantageous in a way that they allow the development of a healthy fetus and prevent the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.

A substantial number of patients with infertility and impaired fecundity are recommended to embrace IVF therapy in combination with PGT procedures, which in turn is expected to stimulate the growth. In addition, public and private authorities are promoting reproductive health by undertaking initiatives is also anticipated to drive the Preimplantation Genetic Testing (PGT) (PGS/PGD) market.

Request a Free Sample Copy of Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Report @ https://www.radiantinsights.com/research/preimplantation-genetic-testing-pgt-pgs-pgd-market/request-sample

Further key findings from the report suggest:

• Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018

• Preimplantation Genetic Screening (PGS) seems to be reasonable intervention to enhance efficiency of selecting chromosomally normal embryo during IVF cycles. It is increasingly being applied for embryo screening due to ever-expanding IVF, which is projected to create lucrative growth opportunities in near future

• Advancements in detection of chromosomal anomalies by executing non-invasive prenatal testing results in a maximum share of this segment in 2018

• Expanding utilization rate of FISH probe sets and benefits associated with the detection of a single-gene disorder is expected to fuel the growth of X-linked diseases segment

• Implementation of PGT in embryo HLA typing for stem cell therapy is expected to impose segment growth. This is further attributed to the advantages pertaining to PGS testing for identification of HLA compatible embryos during stem cell therapy

• Europe accounts for largest revenue share in 2018 owing to increased usage of PGD and PGS for the delivery of genetically healthy offspring during IVF procedures

The report “Preimplantation Genetic Testing (PGT) (PGS/PGD) Market” is available now at https://www.radiantinsights.com/research/preimplantation-genetic-testing-pgt-pgs-pgd-market 

• Asia Pacific market is observed to reveal the fastest CAGR due to the rise in medical tourism and the continuous development of IVF and PGD clinics in Asian countries

• Key players that have commercialized PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others


• Key participants are actively involved in expansion of the distribution network for their products as well as R&D activities for the development of novel PGT services. In October 2018, Illumina Inc. signed an agreement with Vitrolife AB under which Vitrolife act as a distributor supplier of Illumina's PGT products in EMEA and America.

Urea Formaldehyde Fertilizer Market by Geography, Application and Material | Global Industry Forecast to 2023

April 09, 2019: Urea Formaldehyde Fertilizer Market Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

The report firstly introduced the Urea Formaldehyde Fertilizer basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with:
1.) Basic Information;
2.) Asia Urea Formaldehyde Fertilizer Market;
3.) North American Urea Formaldehyde Fertilizer Market;
4.) European Urea Formaldehyde Fertilizer Market;
5.) Market Entry and Investment Feasibility;
6.) Report Conclusion.

The report “Urea Formaldehyde Fertilizer Market” is available now at  https://www.radiantinsights.com/research/global-urea-formaldehyde-fertilizer-market-research-report-2019

Table of Contents

Part I Urea Formaldehyde Fertilizer Industry Overview

Chapter One Urea Formaldehyde Fertilizer Industry Overview
1.1 Urea Formaldehyde Fertilizer Definition
1.2 Urea Formaldehyde Fertilizer Classification Analysis
1.2.1 Urea Formaldehyde Fertilizer Main Classification Analysis
1.2.2 Urea Formaldehyde Fertilizer Main Classification Share Analysis
1.3 Urea Formaldehyde Fertilizer Application Analysis
1.3.1 Urea Formaldehyde Fertilizer Main Application Analysis
1.3.2 Urea Formaldehyde Fertilizer Main Application Share Analysis
1.4 Urea Formaldehyde Fertilizer Industry Chain Structure Analysis
1.5 Urea Formaldehyde Fertilizer Industry Development Overview
1.5.1 Urea Formaldehyde Fertilizer Product History Development Overview
1.5.1 Urea Formaldehyde Fertilizer Product Market Development Overview
1.6 Urea Formaldehyde Fertilizer Global Market Comparison Analysis
1.6.1 Urea Formaldehyde Fertilizer Global Import Market Analysis
1.6.2 Urea Formaldehyde Fertilizer Global Export Market Analysis
1.6.3 Urea Formaldehyde Fertilizer Global Main Region Market Analysis
1.6.4 Urea Formaldehyde Fertilizer Global Market Comparison Analysis
1.6.5 Urea Formaldehyde Fertilizer Global Market Development Trend Analysis

Chapter Two Urea Formaldehyde Fertilizer Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Urea Formaldehyde Fertilizer Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Request a Free Sample Copy of Urea Formaldehyde Fertilizer Market Report @    https://www.radiantinsights.com/research/global-urea-formaldehyde-fertilizer-market-research-report-2019/request-sample

Part II Asia Urea Formaldehyde Fertilizer Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Urea Formaldehyde Fertilizer Market Analysis
3.1 Asia Urea Formaldehyde Fertilizer Product Development History
3.2 Asia Urea Formaldehyde Fertilizer Competitive Landscape Analysis
3.3 Asia Urea Formaldehyde Fertilizer Market Development Trend

Chapter Four 2014-2019 Asia Urea Formaldehyde Fertilizer Productions Supply Sales Demand Market Status and Forecast
4.1 2014-2019 Urea Formaldehyde Fertilizer Production Overview
4.2 2014-2019 Urea Formaldehyde Fertilizer Production Market Share Analysis
4.3 2014-2019 Urea Formaldehyde Fertilizer Demand Overview
4.4 2014-2019 Urea Formaldehyde Fertilizer Supply Demand and Shortage
4.5 2014-2019 Urea Formaldehyde Fertilizer Import Export Consumption
4.6 2014-2019 Urea Formaldehyde Fertilizer Cost Price Production Value Gross Margin

Surgical Imaging Arms Market Conditions, Focusing On The Main Regions and The Main Countries

March 28, 2019: The report firstly introduced the Surgical Imaging Arms basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Request a Free Sample Copy of Surgical Imaging Arms Market Report @  https://www.radiantinsights.com/research/global-surgical-imaging-arms-market-research-report-2019/request-sample

Surgical Imaging Arms Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

The report includes six parts, dealing with:
1.) Basic Information;
2.) Asia Surgical Imaging Arms Market;
3.) North American Surgical Imaging Arms Market;
4.) European Surgical Imaging Arms Market;
5.) Market Entry and Investment Feasibility;
6.) Report Conclusion.

Download Full Research Report on “Surgical Imaging Arms Market” @  
 https://www.radiantinsights.com/research/global-surgical-imaging-arms-market-research-report-2019

Table of Contents

Part I Surgical Imaging Arms Industry Overview

Chapter One Surgical Imaging Arms Industry Overview
1.1 Surgical Imaging Arms Definition
1.2 Surgical Imaging Arms Classification Analysis
1.2.1 Surgical Imaging Arms Main Classification Analysis
1.2.2 Surgical Imaging Arms Main Classification Share Analysis
1.3 Surgical Imaging Arms Application Analysis
1.3.1 Surgical Imaging Arms Main Application Analysis
1.3.2 Surgical Imaging Arms Main Application Share Analysis
1.4 Surgical Imaging Arms Industry Chain Structure Analysis
1.5 Surgical Imaging Arms Industry Development Overview
1.5.1 Surgical Imaging Arms Product History Development Overview
1.5.1 Surgical Imaging Arms Product Market Development Overview
1.6 Surgical Imaging Arms Global Market Comparison Analysis
1.6.1 Surgical Imaging Arms Global Import Market Analysis
1.6.2 Surgical Imaging Arms Global Export Market Analysis
1.6.3 Surgical Imaging Arms Global Main Region Market Analysis
1.6.4 Surgical Imaging Arms Global Market Comparison Analysis
1.6.5 Surgical Imaging Arms Global Market Development Trend Analysis

Chapter Two Surgical Imaging Arms Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Surgical Imaging Arms Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Surgical Imaging Arms Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Surgical Imaging Arms Market Analysis
3.1 Asia Surgical Imaging Arms Product Development History
3.2 Asia Surgical Imaging Arms Competitive Landscape Analysis
3.3 Asia Surgical Imaging Arms Market Development Trend

Chapter Four 2014-2019 Asia Surgical Imaging Arms Productions Supply Sales Demand Market Status and Forecast
4.1 2014-2019 Surgical Imaging Arms Production Overview
4.2 2014-2019 Surgical Imaging Arms Production Market Share Analysis
4.3 2014-2019 Surgical Imaging Arms Demand Overview
4.4 2014-2019 Surgical Imaging Arms Supply Demand and Shortage
4.5 2014-2019 Surgical Imaging Arms Import Export Consumption
4.6 2014-2019 Surgical Imaging Arms Cost Price Production Value Gross Margin

Blood Viscometer Market Detailed Historical Analysis And Extensive Forecasts From 2018-2028

March 22, 2019: The global Blood Viscometer Market was valued at $XX million in 2017, and Radiant Insights analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Blood Viscometer from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Blood Viscometer market.

Leading players of Blood Viscometer including:
• Anton Paar
• Thermo Fisher Scientific
• Brookfield
• RheoSense
• Health Onvector
• BioFluid Technology
• LAUDA
• LAMY RHEOLOGY
• Benson Viscometers
• HRD

Market split by Type, can be divided into:
• Rotational Viscometer
• Capillary Viscometer

Request a Free Sample Copy of Blood Viscometer Market Report @   https://www.radiantinsights.com/research/2013-2028-report-on-global-blood-viscometer-market/request-sample

Market split by Application, can be divided into:
• Hospital
• Clinic
• Laboratory

Market split by Sales Channel, can be divided into:
• Direct Channel
• Distribution Channel

segment by Region/Country including:
• North America
Market
(United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

For further inquiries, about - Global Industry Analysis, Size, Growth, Trends and Forecast 2017 - 2021, click on this link – https://www.radiantinsights.com/research/2013-2028-report-on-global-blood-viscometer-market

Load Balancing Software Market Will Rise Due To It’s High Availability With Scalable Work Force Distribution

March 14, 2019: This report focuses on the global Load Balancing Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Load Balancing Software development in United States, Europe and China.

Load balancing software solution distributes load of work among various servers through software-defined networks and virtual network resources. The load balancing software augments load balancing capability and provides high availability with scalable work force distribution. Through various deployment modes such as cloud and on-premise deployment, various industry players including IBM Corporation, KEMP Technologies, Inc., Google Inc., and others are offering efficient load balancing software in the global market.

Request a Free Sample Copy of Load Balancing Software Market Report @  https://www.radiantinsights.com/research/global-load-balancing-software-market-size-status-and-forecast-2018-2025/request-sample

The global load balancing software market is expected to register substantial growth in the near future, attributed to rise in ICT spending by governments in several developed as well as developing regions including North America, Europe, and Asia-Pacific. In addition, rise in concerns over data loss, recovery, and server load management give rise to the load balancing software industry among several user groups such as large and small and medium enterprises. However, security concerns over cloud load balancing is expected to restrain the growth of the market.

In 2017, the global Load Balancing Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
• Hewlett Packard
• IBM Corporation
• Microsoft Corporation
• Google Inc
• Cisco Systems Inc
• Jetnexus Solutions Limited
• KEMP Technologies, Inc
• ZEVENET
• NGINX Inc
• Inlab Networks GmbH

Market segment by Type, the product can be split into
• Software
• Service

For further inquiries, about - Global Load Balancing Software Market Analysis, Size, Growth, Trends and Forecast 2018 - 2025, click on this link –https://www.radiantinsights.com/research/global-load-balancing-software-market-size-status-and-forecast-2018-2025

Market segment by Application, split into
• Cloud
• On-premise

Market segment by Regions/Countries, this report covers
• United States
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:
• To analyze global Load Balancing Software status, future forecast, growth opportunity, key market and key players.
• To present the Load Balancing Software development in United States, Europe and China.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the Load Balancing Software Market Size are as follows:
• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global & US Gene Therapy Market Will Grow Due To Growing Occurrence Of Life-Threatening And Chronic Disorders

February 25, 2019: Global & US Gene Therapy Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. Gene Therapy is a technique designed to introduce genetic material into cells to compensate for abnormal genes or to make a useful protein to prevent or treat genetic disease. It is also called as human gene transfer technique.

The factors that are playing a major role in the growth of Gene Therapy Market are growing occurrence of life-threatening and chronic disorders, increasing concentration to accelerate commercialization of gene therapy in developed nations. However, the high cost of gene therapy and strict regulatory laws and safety concerns are the factors restraining overall market growth in the years to come. Gene Therapy Market is segmented based on vectors type, approved gene therapy, application, and region.

Request a Free Sample Copy of Gene Therapy Market Report @  https://www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020/request-sample

Non-viral vectors and viral vectors are the vector’s type that could be explored in Gene Therapy in the forecast period. Non-viral vectors include a gene-activated matrix, naked DNA/plasmid vectors, liposomes, lipoplexes and polyplexes, and oligonucleotides. On the other hand, viral vectors comprise lentiviral vectors, adenoviral vectors, retroviral vectors, and adeno-associated virus vectors.
Based on approval of Gene Therapy is segmented into Gendicine, Rexin-G, Oncorine, Neovasculgen, and Glybera. The market may be categorized based on applications like genetic diseases, oncology, neurological diseases, cardiovascular diseases, infectious diseases, and others could be explored in the forecast period. Gene Therapy Market is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific (India, China, Japan, New Zealand, and Australia), Middle East (UAE, Saudi, and Qatar) and Africa (South Africa).
Globally, North America may account for the significant market share of Gene Therapy and is estimated to lead the overall market in the years to come.

 The United States is projected to lead the overall market in terms of revenue. The reason behind the overall market growth could be the presence of key manufacturers in this region. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period.

The key players of Gene Therapy Market are Sibiono GeneTech Co. Ltd., Spark Therapeutics, LLC, Shanghai Sunway Biotech Co. Ltd., ViroMed Co. Ltd. dba VM BioPharma, Human Stem Cells Institute, Advantagene Inc., UniQure N.V., Bluebird Bio, Genethon, Sanofi, Oxford BioMedica Plc, and Vical Inc. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition.

The report “Global & US Gene Therapy Market Forecast to 2020” is available now at  https://www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches are being performed across the globe to explore the potential of gene therapy for the treatment of incurable diseases, such as diabetes, cancer, and HIV amongst others.

According to Radiant Insights new research report "Global & US Gene Therapy Market Forecast to 2020”, most of the gene therapy researches are being focused on finding the treatment for cancer, followed by genetic diseases and neurological disorders, respectively. In this context, the gene therapy application chapter of the report provides a comprehensive overview of various diseases in which the gene therapy is used, along with the current and future market size of gene therapy for particular disease and its geographical break up. Primarily, the gene therapy market is dominated by oncology applications, with several companies and academic institutions focusing on novel and ‘difficult to treat’ cancers. Other therapeutic areas seeking developments in gene therapy include monogenic diseases, cardiovascular diseases, infectious diseases, inherited blindness and neurological diseases. Furthermore, the chapter also provides details regarding the various aspects of the clinical trials in the different gene therapy application by phases, vector types, etc.

The major part of the revenue of gene therapy market is generated from research phase. Most of the gene therapy products are in research phases, only few products have been commercialized till date. The report also provides the sales of major marketed gene therapy products, and the list of the products in clinical/pre-clinical research along with their clinical phases.

To read more reports of this category, Visit our blog:  https://healthandpharamceuticalri.blogspot.com

The companies operating in the gene therapy market are also receiving various funding, grants, and investment from government bodies and venture capitalist firms which are aiding them to develop new products. The study highlights the applications for which the investments have been received.
North America continues to have the maximum number of clinical trials in the gene therapy segment. This is a major reason for the dominant position of North America in the gene therapy market. Based on the geography, the market is divided into four regions, namely, North America, Europe, Asia, and Rest of the World. The report provides the market for each of the geography, along with its forecast till 2020.

This report, further covers how major trends and drivers, mainly gene silencing, advanced therapies combining gene therapy and stem cell technology, immunodeficiency syndromes, growing interest of venture capital firms, etc. will propel the industry’s growth. An analysis has also been done of a few factors limiting the growth of the industry. The report also provides insights regarding the strategies adopted by the players from 2013 to 2015 for enhancing their market share. Finally, with a view to understand the competitive landscape, the profiles of key market players have been included in the report to present a complete picture of the global gene therapy market.

Urinary Catheter Market Is Expected To Grow Due To The Increasing Demand For Minimally Invasive Procedures And Urinary Bladder

February 22, 2019: Global Urinary Catheter Market is expected to grow significantly in the years to come owing to the increasing demand for minimally invasive procedures, growing incidences of kidney failures, cardiovascular diseases, and urinary bladder. Urinary catheters are partially flexible hollow tubes that collect urine from the bladder and accumulates it in a drainage bag. The catheters are made from either rubber, plastic (PVC) or silicone. They are used when an individual is unable to empty the bladder, in cases of urinary incontinence and urinary retention. Bladder, if not emptied, leads to kidney pressure, which may also damage them, sometimes permanent damage. To avoid this kind of risky kidney failure, urinary catheters are used.

Urinary catheter market is driven by increasing number of surgeries for urinary disorders and other relevant illnesses, rise in demand for disposable and sterile catheters, reimbursement policies, and technological advancements in catheters. However, poor quality assurance and stiff price competition are obstructing the market growth. Increasing use of single-mode catheters and self-catheterization is the rising trend witnessed by urinary catheter market. The major challenge faced by urinary catheter market is the significant growth of external catheters segment since they are minimally invasive. The market is categorized on the basis of product, application, and geography. On the basis of product, the market is divided into foley, intermittent, and condom catheters. Intermittent catheter segment is anticipated to lead urinary catheter market owing to its features like easy usage, cost-efficient, reduced risk of further infections and increasing demand.

Based on application, urinary catheter market is bifurcated into bladder dysfunction, urinary incontinence, spinal cord injury and benign prostate hyperplasia. Urinary incontinence segment is predicted to hold larger share of the market due to growing number of patients suffering from the condition. Geographically, urinary catheter market is segmented as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Latin America is anticipated to dominate the market due to increasing incidences for urinary catheters and growing government initiatives for the development of healthcare facilities.

Request a Free Sample Copy of Urinary Catheter Market Report @  https://www.radiantinsights.com/research/global-urinary-catheter-market-outlook-2018-2023/request-sample 

The leading market participants in urinary catheter market are Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc., Teleflex Incorporated, Bard Medical, B. Braun Melsungen AG, Becton Dickinson and Company, Johnson & Johnson, Vascular Solutions, Inc. and Edwards Lifesciences Corp. The report segments the market and forecasts its size, by volume and value, on the basis of product, by application, and by geography (North America, Europe, Asia-Pacific, MEA and South America). The report covers forecast and analysis for the urinary catheter market on a global and regional level. The study provides historic data of 2013-2017 along with a forecast from 2018 to 2023 based on both output/volume and revenue. The study then describes the drivers and restraints for the urinary catheter market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the urinary catheter market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global urinary catheter market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. The research report provides analysis and information according to market segments such as geographies, types and applications. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global urinary catheter market.

The report “Global Urinary Catheter Market Outlook 2018-2023” is available now at  https://www.radiantinsights.com/research/global-urinary-catheter-market-outlook-2018-2023 

Key Regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key Vendors
- request free sample to get a complete list of companies

Key Questions Answered in this Report
- What will the market size be in 2023?
- What are the key factors driving the global urinary catheter market?
- What are the challenges to market growth?
- Who are the key players in the urinary catheter market?
- What are the market opportunities and threats faced by the key players?

Blood Gas Analyzer Market Is Estimated To Lead The Overall Market In The Years To Come

February 20, 2019: Global blood gas analyzer market is expected to grow at a significant CAGR of 6.6% by 2023 as the scope and its applications are rising enormously across the globe. Blood gas analyzer (BGA) is a benchtop or handheld device that measures the concentration of hydrogen ions (pH), partial pressure of oxygen (pO2), and the partial pressure of carbon dioxide (pCO2). Also, can measure metabolites and electrolyte parameters from whole blood specimens. The factors that are playing a major role in the growth of blood gas analyzer market are rising demand for personalized medicines, growing number of retail clinics, rising use of innovative diagnostic equipment’s, and developing whole genome technology. However, the presence of alternatives may restrain overall market growth in the years to come. Blood gas analyzer market is segmented based on product type, application, and region.

Request a Free Sample Copy of Blood Gas Analyzer Market Report @  https://www.radiantinsights.com/research/global-blood-gas-analyzer-market-outlook-2018-2023/request-sample

Benchtop and portable are the product types of blood gas analyzer and is estimated to lead the overall market in the years to come. Portable analyzers sector may account for the significant market share of blood gas analyzer and is estimated to continue its dominance in the years to come. The reason could be rising use of point-of-care (POC) testing. The market may be categorized based on applications like academia, clinics, hospitals, and others that could be explored in blood gas analyzer in the forecast period.

Blood gas analyzer market is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific (India, China, Japan, New Zealand, and Australia), Middle East (UAE, Saudi, and Qatar) and Africa (South Africa). Globally, North America may account for the substantial market share of blood gas analyzer and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be growing several R&D activities and development of new diagnostic procedures. The United States and Canada are the major consumers of blood gas analyzer in this region. Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The developing countries like India and China are the major consumers of blood gas analyzer in this region.

The report “Global Blood Gas Analyzer Market Outlook 2018-2023” is available now at  https://www.radiantinsights.com/research/global-parking-software-market-research-report-2018

The key players of blood gas analyzer market are Siemens Healthineers, Radiometer, Abbott Laboratories, Roche Diagnostics, Accurex Biomedical, Samsung Medison, Medica, Instrumentation Laboratory, and Nova Biomedical. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition. The report segments the market and forecasts its size, by volume and value, on the basis of application (hospital, academia, etc.), and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The report covers forecast and analysis for the Blood Gas Analyzer market on a global and regional level. The study provides historic data of 2013-2017 along with a forecast from 2018 to 2023 based on both output/volume and revenue. The study then describes the drivers and restraints for the Blood Gas Analyzer market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Blood Gas Analyzer market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Blood Gas Analyzer market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

To read more reports of this category, Visit our blog:  https://medicaldevicesmarketreports.tumblr.com  

The research report provides analysis and information according to market segments such as geographies, types and applications. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global Blood Gas Analyzer market.

Key Applications
- Hospital
- Academia

Key Regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key Vendors
- request free sample to get a complete list of companies

Key Questions Answered in this Report
- What will the market size be in 2023?
- What are the key factors driving the global Blood Gas Analyzer market?
- What are the challenges to market growth?
- Who are the key players in the Blood Gas Analyzer market?
- What are the market opportunities and threats faced by the key players?

Live Cell Imaging Market Will Grow At A Higher Rate Due To Availability Of Patient Pool And Prevalence Of Chronic Diseases

February 15, 2019: The global live cell imaging market is projected to grow at a significant CAGR during the forecast period. Live cell imaging is gaining a wider audience since it is used as a popular tool for biological mechanisms and contributes significantly to the functions of multiple cellular processes. Therefore, it is necessary for user to perform a live cell imaging near under biological conditions to prevent any ineffective cellular behavior. The drivers for live cell imaging market include rise in funding for R&D and strategic collaborations for drug delivery & research. Subsequently, the market growth is also backed by rise in prevalence of chronic disorders and demand for diagnostic facilities. Increase in R&D and cell development activities enable cell imaging for further reference. Use of imaging for cell biologists helps them understand the fundamental nature of cell structure and function.

Application segment for live cell imaging market includes developmental biology, stem cell & drug discovery, drug genetics, immunology, microbiology and neurobiology. Technological segment for live cell imaging. Geographical segmentation for live cell imaging market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America followed by Europe dominates the live cell imaging market owing to significant investments and funding for research & development. Inception of private research institutes and advances in medical technology is likely to propel the market growth during the forecast period.

The report “Live Cell Imaging Market Outlook 2022” is available now at 
https://www.radiantinsights.com/research/live-cell-imaging-market-outlook-2022

Asia-Pacific regions are likely to grow at a higher rate due to availability of patient pool and prevalence of chronic diseases. Stem cell research and rise in funding for cell and developmental biology is likely to enlarge the market size during the forecast period. The key players in the live cell imaging market include Nikon Corporation, Carl Zeiss, GE Healthcare, Olympus Corporation, Thermo Fisher Scientific Inc, Sigma-Aldrich Corporation, Molecular Devices LLC and Perkin Elmer Inc. Live Cell Imaging is defined as the study of living cells using high content screening or analysis systems and imaging systems such as microscopes, cell analyzers, etc. These technologies are used in number of investigations in order to provide critical insights into the fundamental nature of tissue and cellular function. The live cell imaging market is expected to reach US$ 7 Billion by 2022.

The report presents an in-depth analysis of several techniques used in imaging of live cells; as well as the segmentation of market by products, applications, technology and geography. Based on product types, the market has been segmented into equipment’s, consumables and software’s. Equipment market is expected to account for the largest share in 2016. According to technologies used in live cell imaging, the market has been divided into FRET, FISH, and other major techniques.

Request a Free Sample Copy of Live Cell Imaging Market Report @  https://www.radiantinsights.com/research/live-cell-imaging-market-outlook-2022/request-sample 

Similarly, geographical regions include North America, Europe, Asia Pacific and Rest of the World. North America is the largest market for live cell imaging due to high number of cell biology researches conducted in the region. As per Radiant Insights' analysis, live cell imaging is widely entering into a number of fields such as cell biology, developmental biology, drug discovery, stem cell biology, neurobiology and electrophysiology. It is emerging as a powerful tool for providing critical insights into cell function, including dynamic processes in living cells with nano-scale resolution in real time. Recent advances in microscopy techniques such as fluorescence light microscopy, including super resolution, photo activation, etc. and confocal microscopy are moving live cell imaging for a number of applications.

The last section of the report discusses about the prominent players in global live cell imaging market. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development and strength weakness analysis of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global live cell imaging market.